RUN Gastroenterology

Version vom 15. Juni 2020, 16:29 Uhr

32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32303607 2020. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
32363528 ä. Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
32350734 ä. Hernia in the time of COVID-19
32314563 ä. Responding to COVID-19: Perspectives from the Chinese Society of Gastroenterology
32272113 ä. Management of Patients with Crohn?s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting
32360567 ä. Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn?s and Colitis Organization (ECCO)
32353371 ä. Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review
32362732 ä. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19
32221526 ä. COVID-19 Outbreak and Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice
32215548 ä. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
32211765 ä. Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience
32330477 ä. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain)
32305331 ä. Inflammatory bowel diseases and COVID-19: the invisible enemy
32298769 ä. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
32283100 ä. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
32283134 ä. Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia
32362368 ä. Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: changes in treatment modalities related to the COVID-19 health crisis
32276846 ä. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time
32321117 2020. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
32360133 ä. Screening for Active COVID-19 Infection and Immunization Status Prior to Biologic Therapy in IBD Patients at the Time of the Pandemic Outbreak
32289115 2020. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
32355509 ä. (appendicitis conservative)
32281517 2020. The daily impact of COVID-19 in gastroenterology
32296473 ä. ... appendicectomie?
32327626 2020. Management of inflammatory bowel disease during COVID-19 pandemic
32192627 2020. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel
32333844 ä. Screening (fec.microb.tp) FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification
32311321 ä. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
32214232 ä. Management of IBD during the COVID-19 outbreak: resetting clinical priorities
32292589 2020. Preventive strategies used by GI physicians during the COVID-19 pandemic
32349198 2020. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic
32279480 2020. Impact of COVID 19: perspectives from gastroenterology
C7197619 ä. Use of the Endoscopic Healing Index (EHI) for Monitoring of Disease Activity in Crohn?s Disease Patients in the COVID Era
32387541 ä. SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
32377636 ä. The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
C7184458 ä. IBD in the Time of COVID19
32292589 2020. Preventive strategies used by GI physicians during the COVID-19 pandemic

32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases